investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
Joan Massague
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Joan Massague
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Jianmin Zhang
Hippo signaling pathway in breast cancer disparities: a translational approach
Breast
Judith A Varner
Role of PI3Kinase Gamma in Tumor Progression and Metastasis
Breast
David T Breault
Characterization of Telomerase Expressing Intestinal Stem Cells
Colorectum
Heather Elizabeth Wheeler
Pharmacogenomics of the Chemotherapeutic Agent Paclitaxel
Breast
Thomas Ried
Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy
Colorectum
Radiation Oncology
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Breast
Amanda Irene Phipps
Lifestyle Factors and Survival Outcomes for Colorectal Cancer Molecular Subtypes
Colorectum
Douglas C Marchion
Development of a Genomic Expression Signature Associated with Chemoresistance
Breast
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Breast